1. Home
  2. JAGX vs NXTT Comparison

JAGX vs NXTT Comparison

Compare JAGX & NXTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
    SELLHOLDBUYas of 3 hours ago
  • NXTT
    SELLHOLDBUYas of 3 hours ago
  • Stock Information
  • Founded
  • JAGX 2013
  • NXTT 2019
  • Country
  • JAGX United States
  • NXTT China
  • Employees
  • JAGX N/A
  • NXTT N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • NXTT
  • Sector
  • JAGX Health Care
  • NXTT
  • Exchange
  • JAGX Nasdaq
  • NXTT NYSE
  • Market Cap
  • JAGX 3.1M
  • NXTT 3.5M
  • IPO Year
  • JAGX N/A
  • NXTT N/A
  • Fundamental
  • Price
  • JAGX $4.99
  • NXTT $0.25
  • Analyst Decision
  • JAGX
  • NXTT
  • Analyst Count
  • JAGX 0
  • NXTT 0
  • Target Price
  • JAGX N/A
  • NXTT N/A
  • AVG Volume (30 Days)
  • JAGX 43.3K
  • NXTT 293.1K
  • Earning Date
  • JAGX 05-13-2025
  • NXTT 05-19-2025
  • Dividend Yield
  • JAGX N/A
  • NXTT N/A
  • EPS Growth
  • JAGX N/A
  • NXTT N/A
  • EPS
  • JAGX N/A
  • NXTT 3.73
  • Revenue
  • JAGX $11,689,000.00
  • NXTT $1,800,000.00
  • Revenue This Year
  • JAGX $38.22
  • NXTT N/A
  • Revenue Next Year
  • JAGX $39.96
  • NXTT N/A
  • P/E Ratio
  • JAGX N/A
  • NXTT $0.07
  • Revenue Growth
  • JAGX 19.75
  • NXTT N/A
  • 52 Week Low
  • JAGX $4.02
  • NXTT $0.24
  • 52 Week High
  • JAGX $540.00
  • NXTT $6.59
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 26.38
  • NXTT 24.97
  • Support Level
  • JAGX $4.02
  • NXTT $0.24
  • Resistance Level
  • JAGX $4.97
  • NXTT $0.27
  • Average True Range (ATR)
  • JAGX 0.56
  • NXTT 0.03
  • MACD
  • JAGX 0.37
  • NXTT 0.03
  • Stochastic Oscillator
  • JAGX 37.94
  • NXTT 8.65

Stock Price Comparison Chart: JAGX vs NXTT

JAGX
NXTT
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April050100150200250300350400450500JAGX VS NXTT

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About NXTT NEXT TECHNOLOGY HOLDING INC

Next Technology Holding Inc pursues two corporate strategies. One business strategy is to continue providing software development services, and the other strategy is to acquire and hold Bitcoin. It provides AI-enabled software development services to its customers, which include developing, designing, and implementing various SAAS software solutions for businesses of all types, including industrial and other businesses. Its bitcoin acquisition strategy generally involves acquiring bitcoin with its liquid assets that exceed working capital requirements, and from time to time, subject to market conditions, issuing debt or equity securities or engaging in other capital raising transactions to use the proceeds to purchase bitcoin.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use